Anti-Diabetic Potential of Murraya Koenigii (L.) and its Antioxidant Capacity in Nicotinamide-Streptozotocin Induced Diabetic Rats

Abstract

Aim and Objective The present study aims to investigate whether the antihyperglycemic effect of Murraya koenigii is mediated by antioxidant properties and insulin mimetic effect.

Methods Thirty Spraque-Dawley rats were induced hyperglycemia by streptozotocin and nicotinamide (STZ-NA). The STZ-NA diabetic rats were treated with an ethanolic extract of Murraya koenigii 200 mg/kg b.w and 400 mg/kg b.w. One group was treated with glibenclamide (1 mg/kg b.w). After the administration of Murraya koenigii extract and glibenclamide for four weeks, the rats were sacrificed. Blood and organ samples were collected under a fasting condition. The body weight and blood glucose levels were measured. Hepatic enzymes were determined using a commercial kit, protein levels were estimated by Bradford’s method, and plasma insulin was assayed by an ELISA kit. Malondialdehyde (MDA) and reduced glutathione (GSH) levels were estimated by the TBA-Wills method and Ellman’s method, respectively.

Results Ethanolic extract of Murraya koenigii showed a significant reduction in blood glucose level at both doses, 200 and 400 mg/kg b.w. In addition, Murraya koenigii exhibited a profound antioxidant effect with decreased MDA level and increased GSH level, particularly at the 200 mg/kg b.w. and significantly decreased the HOMA-IR index.

Conclusions The present study reveals that Murraya koenigii possesses antidiabetic activity and antioxidant effects on STZ-NA induced diabetes mellitus.

Key words

Diabetes - Murraya koenigii - oxidative stress - streptozotocin-nicotinamide

• References

• 1 IDF. IDF Diabetes Atlas. International Diabetes Federation 2015; 1-163
• 2 Soewondo P, Ferrario A, Tahapary DL. Challenges in diabetes management in Indonesia: A literature review. Global Health 2013; 9: 63-80
• 3 Diabetes DOF. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33: (Suppl 1):
• 4 Pazdro R, Burgess JR. The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev. 2010; 131: 276-286
• 5 Brownlee M. A radical explanation for glucose-induced beta cell dysfunction. J Clin Invest. 2003; 112: 1788-1790
• 6 Pethe M, Yelwatkar S, Manchalwar S. et al. Evaluation of Biological Effects of Hydroalcoholic Extract of Hibiscus Rosa Sinensis Flowers on Alloxan Induced Diabetes in Rats. Drug Res (Stuttg) 2017; 67: 485-492
• 7 Patel DK, Prasad SK, Kumar R. et al. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac J Trop Biomed. 2012; 2: 320-330
• 8 Arulselvan P, Ghofar HAA, Karthivashan G. et al. Antidiabetic therapeutics from natural source: A systematic review. Biomed Prev Nutr 2014; 4: 607-617
• 9 Chakraborty DP, Barman BK, Bose PK. On the constitution of murrayanine, a carbazole derivative isolated from Murraya koenigii Spreng. Tetrahedron 1965; 21: 681-685
• 10 Birari R, Javia V, Bhutani KK. Antiobesity and lipid lowering effects of Murraya koenigii (L.) Spreng leaves extracts and mahanimbine on high fat diet induced obese rats. Fitoterapia 2010; 81: 1129-1133
• 11 Khan BA, Abraham A, Leelamma S. Role of Murraya koenigii (curry leaf) and Brassica juncea (Mustard) in lipid peroxidation. Indian J Physiol Pharmacol. 1996; 40: 155-158
• 12 Ningappa MB, Dinesha R, Srinivas L. Antioxidant and free radical scavenging activities of polyphenol-enriched curry leaf (Murraya koenigii L.) extracts. Food Chem. 2008; 106: 720-728
• 13 Yankuzo H, Ahmed QU, Santosa RI. et al. Beneficial effect of the leaves of Murraya koenigii (Linn.) Spreng (Rutaceae) on diabetes-induced renal damage in vivo. J Ethnopharmacol. 2011; 135: 88-94
• 14 Yadav S, Vats V, Dhunnoo Y. et al. Hypoglycemic and antihyperglycemic activity of Murraya koenigii leaves in diabetic rats. J Ethnopharmacol. 2002; 82: 111-116
• 15 Kesari AN, Kesari S, Singh SK. et al. Studies on the glycemic and lipidemic effect of Murraya koenigii in experimental animals. J Ethnopharmacol. 2007; 112: 305-311
• 16 Harborne JB. Phytochemical Methods A Guide To Modern Tecniques Of Plant Analysis. Third EditionChapman Hall; 1998 58:
• 17 OECD. Guidance Document on Acute Oral Toxicity Testing. 2001; 1-24
• 18 Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-254
• 19 Uchiyama M, Mihara M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978; 86: 271-278
• 20 Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959; 82: 70-77
• 21 Aboonabi A, Rahmat A, Othman F. Antioxidant effect of pomegranate against streptozotocin-nicotinamide generated oxidative stress induced diabetic rats. Toxicol Reports 2014; 1: 915-922
• 22 Shukla K, Dikshit P, Tyagi MK. et al. Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide-streptozotocin induced diabetes mellitus. Food Chem Toxicol. 2012; 50: 3595-3599
• 23 Grover JK, Yadav S, Vats V. Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol. 2002; 81: 81-100
• 24 Singh AP, Wilson T, Luthria D. et al. LC-MS-MS characterisation of curry leaf flavonols and antioxidant activity. Food Chem. 2011; 127: 80-85
• 25 Nagappan T, Ramasamy P, Wahid MEA. et al. Biological activity of carbazole alkaloids and essential oil of murraya koenigii against antibiotic resistant microbes and cancer cell lines. Molecules 2011; 16: 9651-9664
• 26 Ma Q, Tian J, Yang J. et al. Bioactive carbazole alkaloids from Murraya koenigii (L.) Spreng. Fitoterapia 2013; 87: 1-6
• 27 Chaves MM, Pereira JS, Maroco J. et al. How plants cope with water stress in the field. Photosynthesis and growth. Ann Bot. 2002; 89 SPEC. ISS. 907-916
• 28 Fröde TS, Medeiros YS. Animal models to test drugs with potential antidiabetic activity. J Ethnopharmacol. 2008; 115: 173-183
• 29 Masiello P, Broca C, Gross R. et al. Development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998; 47: 224-229
• 30 Akahane K, Inoue T, Yokoyama A. et al. Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats. Drug Res (Stuttg) 2014; 65: 416-421
• 31 Arya A, Cheah SC, Looi CY. et al. The methanolic fraction of Centratherum anthelminticum seed downregulates pro-inflammatory cytokines, oxidative stress, and hyperglycemia in STZ-nicotinamide-induced type 2 diabetic rats. Food Chem Toxicol. 2012; 50: 4209-4220
• 32 Tahara A, Matsuyama-Yokono A, Shibasaki M. Effects of antidiabetic drugs in high-fat diet and streptozotocin- nicotinamide-induced type 2 diabetic mice. Eur J Pharmacol. 2011; 655: 108-116
• 33 Kasetti RB, Rajasekhar MD, Kondeti VK. et al Antihyperglycemic and antihyperlipidemic activities of methanol: Water (4:1) fraction isolated from aqueous extract of Syzygium alternifolium seeds in streptozotocin induced diabetic rats. Food Chem Toxicol. 2010; 48: 1078-1084
• 34 Yaribeygi H, Mohammadi MT, Sahebkar A. PPAR-α Agonist Improves Hyperglycemia-Induced Oxidative Stress in Pancreatic Cells by Potentiating Antioxidant Defense System. Drug Res (Stuttg) 2018
• 35 Palsamy P, Sivakumar S, Subramanian S. Resveratrol attenuates hyperglycemia-mediated oxidative stress, proinflammatory cytokines and protects hepatocytes ultrastructure in streptozotocin-nicotinamide-induced experimental diabetic rats. Chem Biol Interact. 2010; 186: 200-210
• 36 Evans JL, Goldfine ID, Maddux BA. et al. Oxidative stress and stress-activated signaling pathways: A unifying hypothesis of type 2 diabetes. Endocr Rev. 2002; 23: 599-622